1. Segment the population and set unifying goals for defined patient groups
Healthcare systems that have performed well during the pandemic focused on achieving outcomes by segmenting the population and using tailored approaches for identified patient groups. All stakeholders—policymakers, providers, payors, and life science companies—must take a similar approach in order for value-based healthcare to work. These stakeholders must define a target segment of the population, create the appropriate healthcare products and services for this demographic, and deliver them to provide value to the patients and the system.
2. Standardize outcomes to define measures of success
For healthcare system stakeholders to collaborate and deliver outcomes for patients, they need to align their efforts toward achieving a common set of outcomes. Policymakers should ensure that healthcare system stakeholders apply these standards consistently, setting the foundation for stakeholders to collaborate and enabling like-for-like comparison of outcomes later on.
For example, the International Consortium for Health Outcomes Measurement (ICHOM) has published global standards on the outcomes that matter most to patients. This nonprofit organization convenes experts and patients worldwide to define patient-reported outcome measures (PROMs) for patients for various conditions, including breast cancer, prostate cancer, diabetes, heart failure, and depression and anxiety.
3. Collect and measure standardized outcomes
Regulators and the public sector should define data standards and establish incentives to collect and report outcomes. They must also ensure that the technological means are available to collect data in a centralized, standardized, and independent manner. In particular, that means using innovative ways to help citizens self-report outcome data and give them access to information on their health status.
Stakeholders can analyze outcome data to identify variations in care and outcomes, enabling them to find the causes of variation, and learn and share leading practices to enhance services.
4. Benchmark and share outcome data
All stakeholders within a value-based healthcare system need to be transparent with their outcome data. By creating a culture of openness, all contributors can share their progress on meeting PROMs and use other stakeholder data to improve their respective services. Regulators and the public sector can play an essential role in establishing outcome registries that support this shared learning and innovation.
Benchmarking outcome data can also help payors inform providers about who their costliest patients are. Such data can help governments focus resources on the socioeconomic determinants of poor health.
As outcome reporting matures, publishing outcomes on a national and global level can help providers and suppliers gain a competitive advantage from the outcomes they are able to achieve. Patients and payors will make more informed decisions based on the outcomes and value they are expected to experience.
5. Implement improvements and keep learning
Value-based healthcare is an ongoing process. Therefore, it is crucial to repeat the cycle of measuring, learning, and improving. Continually, stakeholders need to analyze outcome data, learn from leading practices, implement service improvements, and measure how they contribute to achieving value for patients and the healthcare system.
As part of the learning process, providers should set up forums within their organization to share progress on delivering priority outcomes for patients. By pooling information, providers create accountability and a starting point to reduce variation in care and make care financially efficient. Other specialties and teams can learn from these experiences. They may provide input on how to make services more patient-centered. Providers should join global forums to learn and share leading practices on delivering patient-centered outcomes more effectively.
Payors can use outcome data to work with regulators, introducing value-based payment policies that incentivize providers to deliver high-value patient outcomes and ensure more use of risk-adjusted reimbursement. Life science companies can harness outcome data to assess the efficacy of their products on different patient segments. With these insights, they can develop more effective and personalized treatments, increasing their value to their customers.
Menu